IRADIMED CORPORATION (IRMD)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 03:53PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 540.13M |
| Enterprise Value | 496.94M |
| Trailing P/E | 30.46 |
| Forward P/E | 27.70 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.03 |
| Price/Book (mrq) | 7.10 |
| Enterprise Value/Revenue | 7.34 |
| Enterprise Value/EBITDA | 23.02 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.87 |
| 52-Week Change 3 | -6.08% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 51.04 |
| 52 Week Low 3 | 36.12 |
| 50-Day Moving Average 3 | 42.71 |
| 200-Day Moving Average 3 | 43.70 |
Share Statistics
| Avg Vol (3 month) 3 | 51.12k |
| Avg Vol (10 day) 3 | 54.14k |
| Shares Outstanding 5 | 12.66M |
| Implied Shares Outstanding 6 | 12.66M |
| Float 8 | 7.16M |
| % Held by Insiders 1 | 37.04% |
| % Held by Institutions 1 | 54.36% |
| Shares Short (Apr 30, 2024) 4 | 103.98k |
| Short Ratio (Apr 30, 2024) 4 | 2.74 |
| Short % of Float (Apr 30, 2024) 4 | 1.30% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.82% |
| Shares Short (prior month Mar 28, 2024) 4 | 108.39k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.6 |
| Forward Annual Dividend Yield 4 | 1.41% |
| Trailing Annual Dividend Rate 3 | 0.15 |
| Trailing Annual Dividend Yield 3 | 0.35% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 10.71% |
| Dividend Date 3 | May 30, 2024 |
| Ex-Dividend Date 4 | May 17, 2024 |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 26.48% |
| Operating Margin (ttm) | 26.98% |
Management Effectiveness
| Return on Assets (ttm) | 15.87% |
| Return on Equity (ttm) | 25.52% |
Income Statement
| Revenue (ttm) | 67.69M |
| Revenue Per Share (ttm) | 5.36 |
| Quarterly Revenue Growth (yoy) | 13.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 21.59M |
| Net Income Avi to Common (ttm) | 17.92M |
| Diluted EPS (ttm) | 1.40 |
| Quarterly Earnings Growth (yoy) | 21.40% |
Balance Sheet
| Total Cash (mrq) | 45.13M |
| Total Cash Per Share (mrq) | 3.56 |
| Total Debt (mrq) | 1.94M |
| Total Debt/Equity (mrq) | 2.55% |
| Current Ratio (mrq) | 9.44 |
| Book Value Per Share (mrq) | 6.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 12.7M |
| Levered Free Cash Flow (ttm) | 6.76M |
© 2024 Yahoo. All rights reserved.